This cycle, characterized by high ferroportin and low ferritin levels in M2 TAMs, is supported by the expression of CD91 and CD163, which aid in iron recycling and uptake, thus enhancing tumor spread [198,200]. The gene discussed is SLC40A1; the disease is neoplasm.